Prothena Corp Public (PRTA) Depreciation & Amortization (CF) (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Depreciation & Amortization (CF) of $184000.0 for Q1 2026, down 17.49% year-over-year from $223000.0 in Q1 2025, and down 15.6% quarter-over-quarter from $218000.0 in Q4 2025.
Powered by 
Analysis
Prothena Corp Public (PRTA) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends
Prothena Corp Public's Depreciation & Amortization (CF) history runs 15 years deep, the most recent figure standing at $184000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 17.49% year-over-year to $184000.0; the TTM figure through Mar 2026 stood at $856000.0 (down 4.99% YoY), while the FY2025 annual figure was $895000.0, changed 0.22% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $184000.0, down from $218000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $276000.0 in Q4 2023, with the low at $182000.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $221000.0 (2024), against an average of $214352.9.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) slumped 40.13% in 2022, then jumped 40.82% in 2023.
- Prothena Corp Public's Depreciation & Amortization (CF) stood at $196000.0 in 2022, then surged by 40.82% to $276000.0 in 2023, then decreased by 19.93% to $221000.0 in 2024, then slipped by 1.36% to $218000.0 in 2025, then decreased by 15.6% to $184000.0 in 2026.
- Business Quant data shows PRTA's Depreciation & Amortization (CF) at $184000.0 in Q1 2026, $218000.0 in Q4 2025, and $229000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | - |
| 10 | Prothena Corp Public | 509.98 Mn | 221.78 Mn | - | 197,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 197,000.00 |
| Mar 31, 2026 | 184,000.00 |
| Dec 31, 2025 | 218,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Jun 30, 2025 | 225,000.00 |
| Mar 31, 2025 | 223,000.00 |
| Dec 31, 2024 | 221,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 231,000.00 |
| Mar 31, 2024 | 215,000.00 |
| Dec 31, 2023 | 276,000.00 |
| Sep 30, 2023 | 229,000.00 |
| Jun 30, 2023 | 222,000.00 |
| Mar 31, 2023 | 201,000.00 |
| Dec 31, 2022 | 196,000.00 |
| Sep 30, 2022 | 182,000.00 |
| Jun 30, 2022 | 184,000.00 |
| Mar 31, 2022 | 182,000.00 |
| Dec 31, 2021 | 240,000.00 |
| Sep 30, 2021 | 280,000.00 |